A detailed history of Advisors Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Advisors Capital Management, LLC holds 38,509 shares of GILD stock, worth $3.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
38,509
Previous 12,329 212.34%
Holding current value
$3.6 Million
Previous $846,000 281.68%
% of portfolio
0.05%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $1.74 Million - $2.2 Million
26,180 Added 212.34%
38,509 $3.23 Million
Q2 2024

Aug 09, 2024

SELL
$63.15 - $72.88 $310,445 - $358,278
-4,916 Reduced 28.51%
12,329 $846,000
Q1 2024

May 06, 2024

BUY
$71.58 - $87.29 $288,395 - $351,691
4,029 Added 30.49%
17,245 $1.26 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $30,846 - $34,980
421 Added 3.29%
13,216 $1.07 Million
Q3 2023

Nov 15, 2023

BUY
$73.94 - $80.67 $62,331 - $68,004
843 Added 7.05%
12,795 $959,000
Q2 2023

Aug 03, 2023

SELL
$76.01 - $86.7 $10,413 - $11,877
-137 Reduced 1.13%
11,952 $921,000
Q1 2023

May 04, 2023

BUY
$77.31 - $88.08 $15,771 - $17,968
204 Added 1.72%
12,089 $1 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $45,805 - $65,760
-735 Reduced 5.82%
11,885 $1.02 Million
Q3 2022

Nov 16, 2022

BUY
$59.54 - $68.01 $164,032 - $187,367
2,755 Added 27.93%
12,620 $1.05 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $77,922 - $87,763
-1,350 Reduced 12.04%
9,865 $610,000
Q1 2022

May 10, 2022

SELL
$57.92 - $72.58 $2,432 - $3,048
-42 Reduced 0.37%
11,215 $667,000
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $713 - $810
11 Added 0.1%
11,257 $817,000
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $9,205 - $9,932
-136 Reduced 1.19%
11,246 $786,000
Q2 2021

Aug 02, 2021

BUY
$63.47 - $69.35 $35,035 - $38,281
552 Added 5.1%
11,382 $784,000
Q1 2021

May 12, 2021

SELL
$60.0 - $68.46 $12,180 - $13,897
-203 Reduced 1.84%
10,830 $699,000
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $4,305 - $4,905
-76 Reduced 0.68%
11,033 $642,000
Q3 2020

Nov 05, 2020

SELL
$62.1 - $78.08 $16,332 - $20,535
-263 Reduced 2.31%
11,109 $702,000
Q2 2020

Aug 18, 2020

BUY
$72.34 - $84.0 $55,340 - $64,260
765 Added 7.21%
11,372 $875,000
Q1 2020

May 15, 2020

BUY
$62.63 - $80.22 $83,611 - $107,093
1,335 Added 14.4%
10,607 $793,000
Q4 2019

Jan 10, 2020

BUY
$61.62 - $67.78 $571,340 - $628,456
9,272 New
9,272 $602,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Advisors Capital Management, LLC Portfolio

Follow Advisors Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.